VIVOS INC (RDGL)
Vivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals. Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington. It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Vivos Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 494.21M shares outstanding
USVivos Inc. is a medical technology company focused on radiation oncology, specializing in the development of internal radiation therapy devices for managing tumors that cannot be surgically removed. Their offerings include RadioGel, an injectable particle-gel that utilizes yttrium-90 for targeted radiation treatment of cancerous growths in both humans and animals.
Additionally, the company provides IsoPet, a specific treatment for solid tumors found in animals. Established in 1994, Vivos Inc. is based in Richland, Washington.
It previously operated under the name Advanced Medical Isotope Corporation before rebranding to Vivos Inc. in December 2017.
Leadership
Michael K. Korenko
Chief Executive Officer & Director
Brad Allan Weeks
President
David J. Swanberg
Chief Operating Officer
Carlton Cadwell
Independent Chairman & Secretary
Employees
1
Country
US
Sector
Healthcare
Website
radiogel.com
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Cadwell Carlton M | Director | Grant/Award | 635.3K | -- | Oct 7, 2026 |
| Cadwell Carlton M | Director | Withholding/Transfer | 385.3K | -- | Oct 7, 2026 |
 Korenko Michael K | CEO | Purchase | 200.0K | $99.6K | Sep 30, 2026 |
 Weeks Brad Allan | President | Purchase | 25.6K | $1.2K | Sep 16, 2026 |
| Korenko Michael K | CEO | Purchase | 150.0K | $8.0K | Aug 10, 2026 |
| Weeks Brad Allan | President | Purchase | 50.0K | $2.7K | Aug 10, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
 Korenko Michael K CEO, Director | 11.6M | 2.4% | FORM 4 |
 Weeks Brad Allan President | 1.5M | 0.3% | FORM 4 |
Insiders
- Cadwell Carlton MDirector
- Korenko Michael KCEO
- Weeks Brad AllanPresident
based on 494.21M shares outstanding
US30d Avg
1.01M
60d Avg
905.40K
90d Avg
944.98K